The Analysis Of Final And Surrogate Effectiveness Criteria Used In Health Economic Studies Of Drugs Submitted Into The Reimbursement In Russia In 2016

OBJECTIVES: It is known that different outcomes used in health-economic studies make the comparative effectiveness and calculation of the cost of additional effectiveness complicated. The share of final outcomes used in health-economic evaluations is still unknown. OBJECTIVES. To evaluate the endpoi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A678
Hauptverfasser:	Kolbin, A, Omelianovskiy, VV, Kurylev, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic drugs Asthma Chronic asthma Chronic infection Chronic obstructive pulmonary disease Cost analysis Drugs Health care expenditures Health status Hepatitis HIV Human immunodeficiency virus Hyperplasia Hypertension Infections Prostate Reimbursement Rheumatic diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!